Resulting technology, called SafeGuide, will enable faster, more cost-effective development of gene edited therapies like CRISPR BOSTON & CHICAGO & CAMBRIDGE, England, July 10, 2025--(BUSINESS ...
BOSTON & CAMBRIDGE, England--(BUSINESS WIRE)--Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program (EAP) for ...
Broken String Biosciences launched an early access program (EAP) through which select developers of gene edited therapeutics will be able to use Broken String’s INDUCE-seq ® technology in their own ...
CAMBRIDGE, England--(BUSINESS WIRE)--Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today announced the appointment of new leadership to drive the ...
Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced the ...
Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has entered ...
- Funds to support further development and commercialization of the Company’s INDUCE-seq DNA break mapping technology - Platform technology provides in situ off-target measurement in clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback